Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine.

Biomolecules·2018

Same author

Luminescent dual sensors reveal extracellular pH-gradients and hypoxia on chronic wounds that disrupt epidermal repair.

Theranostics·2014

Same author

Scarring, stem cells, scaffolds and skin repair.

Journal of tissue engineering and regenerative medicine·2014

Same author

Novel macro-microporous gelatin scaffold fabricated by particulate leaching for soft tissue reconstruction with adipose-derived stem cells.

Journal of materials science. Materials in medicine·2012

Same author

Progression of wound pH during the course of healing in burns.

Journal of burn care & research : official publication of the American Burn Association·2012

Same author

Wound contraction is significantly reduced by the use of microcarriers to deliver keratinocytes and fibroblasts in an in vivo pig model of wound repair and regeneration.

Tissue engineering. Part A·2011

Search research articles

Related Experiment Video

Updated: May 3, 2026

A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration

A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration

Published on: March 17, 2018

Strategies Demonstrating Efficacy in Reducing Wound Contraction In Vivo.

Justin R Sharpe¹, Yella Martin¹

¹Blond McIndoe Research Foundation, Queen Victoria Hospital , East Grinstead, United Kingdom .

Advances in Wound Care

|February 15, 2014

Summary

Scarring remains a major clinical issue due to wound contraction. Novel therapies show promise in reducing contraction and improving healing by targeting myofibroblasts.

More Related Videos

Assessment of Acute Wound Healing using the Dorsal Subcutaneous Polyvinyl Alcohol Sponge Implantation and Excisional Tail Skin Wound Models.

Assessment of Acute Wound Healing using the Dorsal Subcutaneous Polyvinyl Alcohol Sponge Implantation and Excisional Tail Skin Wound Models.

Published on: March 25, 2020

Digital Planimetry for Assessing Wound Closure Kinetics in a Mouse Model

Digital Planimetry for Assessing Wound Closure Kinetics in a Mouse Model

Published on: January 10, 2025

Related Experiment Videos

Last Updated: May 3, 2026

A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration

A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration

Published on: March 17, 2018

Assessment of Acute Wound Healing using the Dorsal Subcutaneous Polyvinyl Alcohol Sponge Implantation and Excisional Tail Skin Wound Models.

Assessment of Acute Wound Healing using the Dorsal Subcutaneous Polyvinyl Alcohol Sponge Implantation and Excisional Tail Skin Wound Models.

Published on: March 25, 2020

Digital Planimetry for Assessing Wound Closure Kinetics in a Mouse Model

Digital Planimetry for Assessing Wound Closure Kinetics in a Mouse Model

Published on: January 10, 2025

Area of Science:

Regenerative Medicine
Wound Healing Research
Tissue Engineering

Background:

Scarring is a significant clinical problem, characterized by wound contraction mediated by myofibroblasts.
Wound contracture negatively impacts patient quality of life, affecting function and appearance.

Approach:

Investigated novel tissue-engineered matrices, cell-based therapies, and medicinal therapeutics.
Utilized *in vivo* models to assess the reduction of wound contraction and associated mechanisms.
Employed knockout mouse models to elucidate myofibroblast conversion and tension-generating pathways.

Key Points:

Novel therapies significantly reduced wound contraction in *in vivo* models, often decreasing myofibroblast numbers and improving tissue architecture.
Knockout mouse models have advanced understanding of myofibroblast behavior and wound tension.
Critical assessment of *in vivo* study limitations is necessary due to the lack of perfect animal models for human wound healing.

Conclusions:

Medicinal therapeutics and tissue-engineering strategies targeting myofibroblast pathways offer promising avenues for clinical translation.
Further research is needed to elucidate mechanisms and build confidence for clinical application of novel therapies.
Reducing wound contraction is key to mitigating the negative impacts of scarring on patients.